Company

Drug

Indication


Astellas Pharma Inc. (Tokyo) and Pfizer Inc. (New York)

Xtandi

Metastatic castration-resistant prostate
cancer

Eli Lilly and Co. (Indianapolis)

Lartruvo

Soft tissue sarcoma

Genentech Inc. (South San Francisco)

Lucentis

Wet age-related macular degeneration

Genentech Inc. (South San Francisco; unit of Roche Holdings AG)

Tecentriq

Metastatic non-small-cell lung cancer

Janssen Pharmaceuticals Inc. (Raritan, N.J.)

Xarelto

Atrial fibrillation

Ligand Pharmaceuticals Inc. (San Diego) and Lundbeck A/S (Copenhagen)

Carnexiv

Seizures

Merck & Co Inc. (Kenilworth, N.J.)

Keytruda

Non-small-cell lung cancer (NSCLC)

Merck & Co. Inc. (Kenilworth, N.J.)

Zinplava

Clostridium difficile infection

Orexo AB (Uppsala, Sweden)

Zubsolv

Opioid dependence

Protein Sciences Corp. (Meriden, Conn.)

Flublok

Influenza

Roche Holding AG (Basel, Switzerland)

Ventana

Metastatic non-small-cell lung cancer

 

No Comments